Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Manufacture Advanced Medicine, Drug Delivery, Digital Technologies, Business Practice, Standards & Regulation, Supply Chain, Technology and Equipment

Cell and Gene Champions Speak Up

sponsored by Bio-Rad, Eppendorf, Millipore Sigma, OmniaBio, and Thermo Fisher Scientific

This year, our cell and gene supplement takes a close look at the state of the field, and the problems that it is facing. In the main feature, we draw on the expert takes sent to us throughout 2022 by various cell and gene “Champions” – opinion leaders and innovators observing, researching, and trying to commercialize cutting edge cell and gene therapies. Our champions includeBruce Levine (University of Pennsylvania), Chelsea Pratt (Bio-Rad), Dave Seaward (3P innovation), Miguel Forte (BioSenic), and more. Also included in the supplement:

  • Lentiviral vs adeno-associated – the pros and cons of vector properties
  • How more efficient manufacturing can help meet rare disease needs
  • Nineties nostalgia with a major player from gene therapy’s early days
  • Reaching beyond the lower branches of possible ophthalmic treatments
  • And more!

Itching to dive in? Download the PDF.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Angus Stewart

Associate Editor of The Medicine Maker

Between studying for my English undergrad and Publishing master's degrees I was out in Shanghai, teaching, learning, and getting extremely lost. Now I'm expanding my mind down a rather different rabbit hole: the pharmaceutical industry. Outside of this job I read mountains of fiction and philosophy, and I must say, it's very hard to tell who's sharper: the literati, or the medicine makers.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register